Results 31 to 40 of about 257,176 (353)

ORAL POLIOMYELITIS VACCINE

The Lancet, 1961
C. H. Stuart-Harris, J. Knowelden
  +9 more sources

Oral Delivery of Novel Recombinant Lactobacillus Elicit High Protection against Staphylococcus aureus Pulmonary and Skin Infections

Vaccines, 2021
Staphylococcus aureus is a leading cause of nosocomial and community-associated infection worldwide; however, there is no licensed vaccine available. S.
Na Pan, Bohui Liu, Xuemei Bao, Haochi Zhang, Shouxin Sheng, Yanchen Liang, Haiting Pan, Xiao Wang   +7 more
doaj   +1 more source

Stockpiling oral cholera vaccine

Bulletin of the World Health Organization, 2012
Cholera is re-emerging as a threat on the global public health stage. The number of reported cases worldwide is back at the peak level observed two decades ago,1 new Vibrio cholerae strains have appeared and antimicrobial resistance has increased. Weak surveillance systems and the possibility of travel and trade sanctions contribute to widespread ...
Stephen Martin, Alejandro Costa, William Perea   +2 more
openaire   +3 more sources

Advances in enteric disease vaccines: from innovation to implementation [PDF]

, 2014
The Seventh International Conference on Vaccines for Enteric Diseases Bangkok, Thailand, 6–8 November 2013 Hosting 222 participants from more than 25 countries, the Seventh International Conference on Vaccines for Enteric Diseases (VED 2013) displayed ...
Parker, EPK
core   +1 more source

Formulations of liposomal vaccine containing AdhO36 antigen and β-glucan as immunoadjuvant [PDF]

Pharmaciana, 2021
Humans are the most crucial host of Salmonella typhi as it has limited ability to reproduce outside the human body. S. typhi infections caused typhoid fever which can be prevented with vaccines.
Hidajah Rachmawati, Raditya Weka Nugraheni, Firasti Agung Nugrahening Sumadi, Helmy Yusuf   +3 more
doaj   +1 more source

Mimicking Native Display of CD0873 on Liposomes Augments Its Potency as an Oral Vaccine against Clostridioides difficile

Vaccines, 2021
Mucosal vaccination aims to prevent infection mainly by inducing secretory IgA (sIgA) antibody, which neutralises pathogens and enterotoxins by blocking their attachment to epithelial cells.
Cansu Karyal, Panayiota Palazi, Jaime Hughes, Rhys C. Griffiths, Ruby R. Persaud, Patrick J. Tighe, Nicholas J. Mitchell, Ruth Griffin   +7 more
doaj   +1 more source

Variable protection against experimental broiler necrotic enteritis after immunisation with the C-terminal fragment of Clostridium perfringens alpha-toxin and a non-toxic NetB variant [PDF]

, 2016
Necrotic enteritis toxin B (NetB) is a pore-forming toxin produced by Clostridium perfringens and has been shown to play a key role in avian necrotic enteritis (NE), a disease causing significant costs to the poultry production industry worldwide.
Bokori-Brown, Monika, Fernandes da Costa, Sergio, Geeraerts, Sofie, Mot, Dorien, Titball, Richard, Van Immerseel, Filip   +5 more
core   +3 more sources

Development and evaluation of an oral liposomal vaccine for the prevention of Edwardsiellosis in Anguilla japonica caused by Edwardsiella piscicida

Fisheries and Aquatic Sciences
Edwardsiellosis, caused by Edwardsiella piscicida infection in eels (Anguilla japonica), is a major problem for Korean eel farms, so there is an urgent need to develop a vaccine.
Young Min Woo, Keun Woo Lee, Byung-Chul Jeong, Jae Young Cha, Won-Sik Woo, Chan-Il Park, Young Jae Kim, Dong-Geun Lee, Sang-Hyeon Lee, Jun Cheul Ahn, Andre Kim   +10 more
doaj   +1 more source

A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India

Human Vaccines & Immunotherapeutics, 2018
Background: The World Health Organization recommends that rotavirus vaccines should be included in all national immunization programs. Some currently licensed oral rotavirus vaccines contain a buffering agent (either as part of a ready-to-use liquid ...
Raches Ella, Radhika Bobba, Sanjay Muralidhar, Sudhir Babji, Krishna Mohan Vadrevu, Maharaj Kishan Bhan   +5 more
doaj   +1 more source

Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate

Vaccines, 2021
Various types of vaccines, such as mRNA, adenovirus, and inactivated virus by injection, have been developed to prevent SARS-CoV-2 infection. Although some of them have already been approved under the COVID-19 pandemic, various drawbacks, including ...
Johnny Chun-Chau Sung, Ying Liu, Kam-Chau Wu, Man-Chung Choi, Chloe Ho-Yi Ma, Jayman Lin, Emily Isabel Cheng He, David Yiu-Ming Leung, Eric Tung-Po Sze, Yusuf Khwaja Hamied, Dominic Man-Kit Lam, Keith Wai-Yeung Kwong   +11 more
doaj   +1 more source